Vertex Pharmaceuticals Price Prediction and Hype Density Breakdown

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 35px;;'>VRT</div>
VRTX -- USA Stock  

 Earnings Call  This Week

We analyze noise-free headlines and recent hype associated with Vertex Pharmaceuticals Incorpor which may create opportunities for some arbitrage if properly timed. With Vertex Pharmaceuticals hype-based prediction module you can estimate the value of Vertex Pharmaceuticals Incorpor from the prospective of Vertex Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Vertex Pharmaceuticals over a specific investment horizon. Also please take a look at Vertex Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Vertex Pharmaceuticals After-Hype Price Density Analysis

 Next price density 
    
  Expected price to next headline 

Vertex Pharmaceuticals Estimiated After-Hype Price Volatility

Current Value
234.61
January 25, 2020
230.18
Downside
233.84
After-hype Price
237.50
Upside
Vertex Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Vertex Pharmaceuticals is based on 3 months time horizon.

Vertex Pharmaceuticals Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.28  1.22  0.77   0.00  9 Events / Month3 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
234.61233.840.33 
44.53  

Vertex Pharmaceuticals Hype Timeline

Vertex Pharmaceuticals is at this time traded for234.61. The entity has historical hype elasticity of -0.77 and average elasticity to hype of competition of 0.0. Vertex Pharmaceuticals Incorpor is projected to decline in value after the next headline with price expected to drop to 233.84. The average volatility of media hype impact on the company stock price is about 44.53%. The price decrease on the next news is expected to be -0.33% where as daily expected return is at this time at 0.28%. The volatility of related hype on Vertex Pharmaceuticals is about 7625.0% with expected price after next announcement by competition of 234.61. About 99.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.65. Vertex Pharmaceuticals recorded earning per share (EPS) of 8.24. The entity had not issued any dividends in recent years. The firm had 2:1 split on 2000-08-24. Given the investment horizon of 30 days, the next projected press release will be in about 9 days.
Also please take a look at Vertex Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Vertex Pharmaceuticals Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
Vertex Pharmaceuticals Incorpor(2.74) 9 per month 0.30  0.20  2.79 (1.14)  6.01 
Dr Reddys Laboratories Ltd 0.09 7 per month 1.00  0.011  2.39 (1.81)  6.20 
Sinovac Biotech Ltd 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Zoetis(1.36) 10 per month 1.61  0.0131  1.44 (2.23)  8.38 
Immune Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Perrigo Company Plc 0.60 8 per month 1.51  0.0201  2.79 (1.91)  13.43 
PAREXEL International Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Regeneron Pharmaceuticals 3.51 8 per month 1.51  0.09  2.82 (1.84)  12.69 
SciClone Pharmaceuticals, In 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Origin Agritech Limited 0.06 5 per month 3.57  0.07  9.11 (6.94)  58.70 

Contributor Headline

Latest Prospective on Vertex Pharmaceuticals

Also please take a look at Vertex Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Company logos by clearbit